CARDIOVASCULAR JOURNAL OF AFRICA Volume 27 , No 2, MarchApril 2016 [614111]

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 27 , No 2, March/April 2016
AFRICA 89
physiological changes in pregnancy
Priya Soma-Pillay, Catherine Nelson-Piercy, Heli Tolppanen, Alexandre Mebazaa
abstract
Physiological changes occur in pregnancy to nurture the
developing foetus and prepare the mother for labour and delivery. Some of these changes influence normal biochemical
values while others may mimic symptoms of medical disease.
It is important to differentiate between normal physiological changes and disease pathology. This review highlights the important changes that take place during normal pregnancy.
Keywords: hypercoagulable state, diabetogenic, uterine contrac-
tions
Submitted 31/8/15, accepted 4/3/16
Cardiovasc J Afr 2016; 27: 89–94 www.cvja.co.za
DOI: 10.5830/CVJA-2016-021
During pregnancy, the pregnant mother undergoes significant
anatomical and physiological changes in order to nurture and accommodate the developing foetus. These changes begin after
conception and affect every organ system in the body.
1 For
most women experiencing an uncomplicated pregnancy, these
changes resolve after pregnancy with minimal residual effects.
It is important to understand the normal physiological changes
occurring in pregnancy as this will help differentiate from adaptations that are abnormal.
Haematological changes
Plasma volume increases progressively throughout normal pregnancy.
2 Most of this 50% increase occurs by 34 weeks’ gestation and is proportional to the birthweight of the baby.
Because the expansion in plasma volume is greater than the
increase in red blood cell mass, there is a fall in haemoglobin concentration, haematocrit and red blood cell count. Despite this haemodilution, there is usually no change in mean corpuscular
volume (MCV) or mean corpuscular haemoglobin concentration
(MCHC).
The platelet count tends to fall progressively during normal
pregnancy, although it usually remains within normal limits. In a proportion of women (5–10%), the count will reach levels
of 100–150 × 10
9 cells/l by term and this occurs in the absence
of any pathological process. In practice, therefore, a woman is
not considered to be thrombocytopenic in pregnancy until the
platelet count is less than 100 × 109 cells/l.
Pregnancy causes a two- to three-fold increase in the
requirement for iron, not only for haemoglobin synthesis but
also for for the foetus and the production of certain enzymes.
There is a 10- to 20-fold increase in folate requirements and a
two-fold increase in the requirement for vitamin B12.
Changes in the coagulation system during pregnancy
produce a physiological hypercoagulable state (in preparation
for haemostasis following delivery).3 The concentrations
of certain clotting factors, particularly VIII, IX and X, are
increased. Fibrinogen levels rise significantly by up to 50% and
fibrinolytic activity is decreased. Concentrations of endogenous
anticoagulants such as antithrombin and protein S decrease. Thus pregnancy alters the balance within the coagulation system in favour of clotting, predisposing the pregnant and postpartum
woman to venous thrombosis. This increased risk is present from
the first trimester and for at least 12 weeks following delivery. In
vitro tests of coagulation [activated partial thromboplastin time (APTT), prothrombin time (PT) and thrombin time (TT)] remain normal in the absence of anticoagulants or a coagulopathy.
Venous stasis in the lower limbs is associated with venodilation
and decreased flow, which is more marked on the left. This is due to compression of the left iliac vein by the left iliac artery and the ovarian artery. On the right, the iliac artery does not cross
the vein.
Cardiac changes
Changes in the cardiovascular system in pregnancy are profound
and begin early in pregnancy, such that by eight weeks’ gestation, the cardiac output has already increased by 20%. The primary
event is probably peripheral vasodilatation. This is mediated
by endothelium-dependent factors, including nitric oxide synthesis, upregulated by oestradiol and possibly vasodilatory prostaglandins (PGI
2). Peripheral vasodilation leads to a 25–30%
fall in systemic vascular resistance, and to compensate for this, cardiac output increases by around 40% during pregnancy. This
is achieved predominantly via an increase in stroke volume, but
also to a lesser extent, an increase in heart rate. The maximum cardiac output is found at about 20–28 weeks’ gestation. There is a minimal fall at term. department of obstetrics and Gynaecology, university of
pretoria and Steve Biko academic Hospital, p retoria, South
africa
Priya Soma-Pillay, MB ChB, MMed (O et G) Pret, FCOG, Cert
(Maternal and Foetal Med) SA, Priya.Soma-Pillay@up.ac.za
department of obstetric Medicine, women’s Health academic
Centre, King’s Health p artners; Guy’s and St thomas’
Foundation trust, and Queen Charlotte’s and Chelsea
Hospital, imperial College Healthcare trust, london, uK
Catherine Nelson-Piercy, MA, FRCP , FRCOG
iNSErM uMrS 942, p aris, France
Heli Tolppanen, MDAlexandre Mebazaa, MD
Heart and lung Centre, Helsinki university Central
Hospital, Finland
Heli Tolppanen, MD
university p aris diderot, Sorbonne p aris Cité, p aris;
department of anesthesia and Critical Care, Hôpital
lariboisière, apHp , France
Alexandre Mebazaa, MD

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 27 , No 2, March/April 2016
90
AFRICA
An increase in stroke volume is possible due to the early
increase in ventricular wall muscle mass and end-diastolic
volume (but not end-diastolic pressure) seen in pregnancy. The
heart is physiologically dilated and myocardial contractility
is increased. Although stroke volume declines towards term, the increase in maternal heart rate (10–20 bpm) is maintained, thus preserving the increased cardiac output. Blood pressure
decreases in the first and second trimesters but increases to
non-pregnant levels in the third trimester.
There is a profound effect of maternal position towards
term upon the haemodynamic profile of both the mother and foetus. In the supine position, pressure of the gravid uterus on
the inferior vena cava (IVC) causes a reduction in venous return
to the heart and a consequent fall in stroke volume and cardiac output. Turning from the lateral to the supine position may result in a 25% reduction in cardiac output. Pregnant women
should therefore be nursed in the left or right lateral position
wherever possible. If the woman has to be kept on her back, the pelvis should be rotated so that the uterus drops to the side and off the IVC, and cardiac output and uteroplacental blood flow are optimised. Reduced cardiac output is associated with a reduction in uterine blood flow and therefore in placental
perfusion, which could compromise the foetus.
Although both blood volume and stroke volume increase
in pregnancy, pulmonary capillary wedge pressure and central
venous pressure do not increase significantly. Pulmonary vascular resistance (PVR), like systemic vascular resistance (SVR),
decreases significantly in normal pregnancy. Although there is no
increase in pulmonary capillary wedge pressure (PCWP), serum colloid osmotic pressure is reduced by 10–15%. The colloid osmotic pressure/pulmonary capillary wedge pressure gradient
is reduced by about 30%, making pregnant women particularly
susceptible to pulmonary oedema. Pulmonary oedema will be precipitated if there is either an increase in cardiac pre-load (such as infusion of fluids) or increased pulmonary capillary permeability (such as in pre-eclampsia) or both.
Labour is associated with further increases in cardiac output
(15% in the first stage and 50% in the second stage) Uterine contractions lead to an auto-transfusion of 300–500 ml of blood back into the circulation and the sympathetic response to pain
and anxiety further elevate the heart rate and blood pressure.
Cardiac output is increased between contractions but more so during contractions.
Following delivery there is an immediate rise in cardiac
output due to relief of the inferior vena cava obstruction and contraction of the uterus, which empties blood into the systemic
circulation. Cardiac output increases by 60–80%, followed by
a rapid decline to pre-labour values within about one hour of delivery. Transfer of fluid from the extravascular space increases venous return and stroke volume further.
Those women with cardiovascular compromise are therefore
most at risk of pulmorary oedema during the second stage of labour and the immediate postpartum period. Cardiac output has nearly returned to normal (pre-pregnancy values) two weeks after delivery, although some pathological changes (e.g.
hypertension in pre-eclampsia) may take much longer.
The above physiological changes lead to changes on
cardiovascular examination that may be misinterpreted as
pathological by those unfamiliar with pregnancy. Changes may include a bounding or collapsing pulse and an ejection systolic murmur, present in over 90% of pregnant women. The murmur may be loud and audible all over the precordium, with the first heart sound loud and possibly sometimes a third heart sound.
There may be ectopic beats and peripheral oedema.
Normal findings on ECG in pregnancy that may partly relate
to changes in the position of the heart include:
• atrial and ventricular ectopics
• Q wave (small) and inverted T wave in lead III
• ST-segment depression and T-wave inversion in the inferior and lateral leads
• left-axis shift of QRS.
adaptive changes in renal vasculature
The primary adaptive mechanism in pregnancy is a marked fall in systemic vascular resistance (SVR) occurring by week six of gestation. The 40% fall in SVR also affects the renal vasculature.
4
Despite a major increase in plasma volume during pregnancy, the massive decrease in SVR creates a state of arterial under-filling
because 85% of the volume resides in the venous circulation.
5
This arterial under-filling state is unique to pregnancy. The fall
in SVR is combined with increased renal blood flow and this is in contrast to other states of arterial under-filling, such as cirrhosis,
sepsis or arterio-venous fistulas.
3,6
Relaxin, a peptide hormone produced by the corpus luteum,
decidua and placenta, plays an important role in the regulation
of haemodynamic and water metabolism during pregnancy.
Serum concentrations of relaxin, already elevated in the luteal
phase of the menstrual cycle, rise after conception to a peak at the end of the first trimester and fall to an intermediate value throughout the second and third trimester. Relaxin stimulates
the formation of endothelin, which in turn mediates vasodilation
of renal arteries via nitric oxide (NO) synthesis.
7
Despite activation of the renin–angiotensin–aldosterone
(RAA) system in early pregnancy, a simultaneous relative
resistance to angiotensin II develops, counterbalancing the
vasoconstrictive effect and allowing profound vasodilatation.8
This insensitivity to angiotensin II may be explained by the effects of progesterone and vascular endothelial growth factor-
mediated prostacyclin production, as well as modifications in
the angiotensin I receptors during pregnancy.
9 The vascular
refractoriness to angiotensin II may also be shared by other vasoconstrictors such as adrenergic agonists and arginine
vasopressin (A VP).
10 It is possible that in the second half of
pregnancy, the placental vasodilatators are more important in
the maintenance of the vasodilatatory state.6
Changes in renal anatomy and function
As a consequence of renal vasodilatation, renal plasma flow and glomerular filtration rate (GFR) both increase, compared to non-pregnant levels, by 40–65 and 50–85%, respectively. In
addition, the increase in plasma volume causes decreased oncotic
pressure in the glomeruli, with a subsequent rise in GFR.
11
Vascular resistance decreases in both the renal afferent and efferent arterioles and therefore, despite the massive increase in
renal plasma flow, glomerular hydrostatic pressure remains stable,
avoiding the development of glomerular hypertension. As the GFR rises, both serum creatinine and urea concentrations decrease to mean values of about 44.2 μmol/l and 3.2 mmol/l, respectively.

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 27 , No 2, March/April 2016
AFRICA 91
The increased renal blood flow leads to an increase in renal
size of 1–1.5 cm, reaching the maximal size by mid-pregnancy.
The kidney, pelvis and calyceal systems dilate due to mechanical
compressive forces on the ureters. Progesterone, which reduces
ureteral tone, peristalsis and contraction pressure, mediates these anatomical changes.
11 The increase in renal size is associated with
an increase in renal vasculature, interstitial volume and urinary dead space. There is also dilation of the ureters, renal pelvis
and calyces, leading to physiological hydronephrosis in over
80% of women.
12 There is often a right-sided predominance of
hydronephrosis due to the anatomical circumstances of the right ureter crossing the iliac and ovarian vessels at an angle before
entering the pelvis. Urinary stasis in the dilated collecting system
predisposes pregnant women with asymptomatic bacteriuria to pyelonephritis.
12
There are also alterations in the tubular handling of wastes
and nutrients. As in the non-pregnant state, glucose is freely filtered in the glomerulus. During pregnancy, the reabsorption of
glucose in the proximal and collecting tubule is less effective, with
variable excretion. About 90% of pregnant women with normal blood glucose levels excrete 1–10 g of glucose per day. Due to the increases in both GFR and glomerular capillary permeability to albumin, the fractional excretion of protein may increase up to 300 mg/day and protein excretion also increases. In normal pregnancies
the total protein concentration in urine does not increase above
the upper normal limit. Uric acid excretion also increases due to increased GFR and/or decreased tubular reabsorption.
11
Body water metabolism
Arterial under-filling in pregnancy leads to the stimulation of arterial baroreceptors, activating the RAA and the sympathetic nervous systems. This results in a non-osmotic release of A VP
from the hypothalamus. These changes lead to sodium and
water retention in the kidneys and create a hypervolaemic, hypo-osmolar state characteristic of pregnancy.
6 Extracellular volume
increases by 30–50% and plasma volume by 30–40%. Maternal blood volume increases by 45% to approximately 1 200 to 1 600
ml above non-pregnant values. By the late third trimester the
plasma volume increases by more than 50–60%, with a lower increase in red blood cell mass, and therefore plasma osmolality falls by 10 mosmol/kg. The increase in plasma volume plays
a critical role in maintaining circulating blood volume, blood
pressure and uteroplacental perfusion during pregnancy.
13
Activation of the RAA system leads to increased plasma
levels of aldosterone and subsequent salt and water retention in the distal tubule and collecting duct. In addition to the increased
renin production by the kidneys, ovaries and uteroplacental
unit produce an inactive precursor protein of renin in early pregnancy.
14 The placenta also produces oestrogens that
stimulate the synthesis of angiotensinogen by the liver, resulting in proportionally increased levels of aldosterone compared to
renin. Plasma levels of aldosterone correlate well with those of
oestrogens and rise progressively during pregnancy. The increase in aldosterone is responsible for the increase in plasma volume during pregnancy.
13 Progesterone, which is a potent aldosterone
antagonist, allows natriuresis despite the sodium-retaining properties of aldosterone. The rise in GFR also increases
distal sodium delivery, allowing excretion of excess sodium.
Progesterone has antikaliuretic effects and therefore excretion of potassium is kept constant throughout pregnancy due to changes
in tubular reabsorption, and total body potassium increases
during pregnancy.
6,15
Hypothalamic A VP release increases early in pregnancy as a
result of increased relaxin levels. A VP mediates an increase in water reabsorption via aquaporin 2 channels in the collecting duct. The
threshold for hypothalamic secretion of A VP and the threshold
for thirst is reset to a lower plasma osmolality level, creating the hypo-osmolar state characteristic of pregnancy. These changes are mediated by human chorionic gonadotropin (hCG) and relaxin.
11,16
In middle and late pregnancy there is a four-fold increase in
vasopressinase, an aminopeptidase produced by the placenta. These changes enhance the metabolic clearance of vasopressin
and regulate the levels of active A VP . In conditions of increased
placental production of vasopressinase, such as pre-eclampsia or twin pregnancies, a transient diabetes insipidus may develop.
17
As a consequence of this volume expansion, the secretion of atrial natriuretic peptides increases by 40% in the third trimester,
and rises further during the first week postpartum. The levels of
natriuretic peptides are higher in pregnant women with chronic hypertension and pre-eclampsia.
18
respiratory changes
There is a significant increase in oxygen demand during normal pregnancy. This is due to a 15% increase in the metabolic rate and a 20% increased consumption of oxygen. There is a 40–50%
increase in minute ventilation, mostly due to an increase in
tidal volume, rather than in the respiratory rate. This maternal hyperventilation causes arterial pO
2 to increase and arterial
pCO2 to fall, with a compensatory fall in serum bicarbonate to
18–22 mmol/l (see Table 1). A mild fully compensated respiratory alkalosis is therefore normal in pregnancy (arterial pH 7.44).
Diaphragmatic elevation in late pregnancy results in decreased
functional residual capacity but diaphragmatic excursion and therefore vital capacity remain unaltered. Inspiratory reserve volume is reduced early in pregnancy, as a result of increased
tidal volume, but increases in the third trimester, as a result of
reduced functional residual capacity (see Fig. 1). Peak expiratory flow rate (PEFR) and forced expiratory volume in one second (FEV
1) are unaffected by pregnancy.
Pregnancy may also be accompanied by a subjective feeling of
breathlessness without hypoxia. This is physiological and is most
common in the third trimester but may start at any time during
gestation. Classically, the breathlessness is present at rest or while talking and may paradoxically improve during mild activity.
adaptive changes in the alimentary tract
Nausea and vomiting are very common complaints in pregnancy, affecting 50–90% of pregnancies.
19 This might be an adaptive
table 1. r eference ranges for respiratory function in pregnancy
InvestigationsNormal values
Pregnant Non-pregnant
pH 7.40–7.47 7.35–7.45
pCO2, mmHg (kPa) ≤ 30 (3.6–4.3) 35–40 (4.7–6.0)
pO2, mmHg (kPa) 100–104 (12.6–14.0) 90–100 (10.6–14.0)
Base excess No change +2 to –2
Bicarbonate (mmol/l) 18–22 20–28

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 27 , No 2, March/April 2016
92
AFRICA
mechanism of pregnancy, aiming at preventing pregnant women
from consuming potentially teratogenic substances such as strong-tasting fruits and vegetables. The exact underlying
mechanism is not clear but pregnancy-associated hormones
such as human chorionic gonadotropin (hCG), oestrogen and progesterone could to be involved in the aetiology. The levels of hCG peak at the end of the first trimester when the trophoblast
is most actively producing hCG, correlating with the nausea
symptoms. Nausea is also more frequent in pregnancies with high levels of hCG, such as in twin pregnancies.
Thyroid hormones may also be involved in the development
of nausea symptoms, as a strong association with nausea and
abnormal thyroid function tests has been found. Thyroid-
stimulating hormone (TSH) and hCG have similar biomolecular structures and therefore hCG cross-reacts with TSH, stimulating the thyroid gland.
18 Psychological causes, genetic incompatibility,
immunological factors, nutritional deficiencies as well as Helicobacter pylori infection have been proposed as aetiological
factors of nausea and vomiting during pregnancy.
20
The nausea symptoms usually resolve by week 20 but
about 10–20% of the patients experience symptoms beyond
week 20 and some until the end of the pregnancy.21 In most
cases minor dietary modification and observation of electrolyte balance is sufficient. About 0.5–3% of pregnant women develop
hyperemesis gravidum, a severe form of nausea and excessive
vomiting, often resulting in dehydration, electrolyte imbalance, ketonuria, weight loss and vitamin or mineral deficiencies.
19,21
In these cases intravenous fluid and vitamin substitution is commonly required. Thiamine supplementation is important in
order to avoid the development of Wernicke’s encephalopathy.
22
As pregnancy progresses, mechanical changes in the
alimentary tract also occur, caused by the growing uterus. The
stomach is increasingly displaced upwards, leading to an altered
axis and increased intra-gastric pressure. The oesophageal
sphincter tone is also decreased and these factors may predispose to symptoms of reflux, as well as nausea and vomiting.
23
Changes in oestrogen and progesterone levels also influence
the structural alterations in the gastrointestinal tract. These
include abnormalities in gastric neural activity and smooth
muscle function, leading to gastic dysrhythmia or gastroparesis. The alterations are pronounced in women with pre-existing gastrointestinal diseases such as gastroesophageal reflux disease, diabetic gastroparesis, gastric bypass surgery or inflammatory bowel disease.
21,23
Endocrine changes
Thyroid
There is an increase in the production of thyroxine-binding globulin
(TBG) by the liver, resulting in increased levels of thyroxine (T4)
and tri-iodothyronine (T3). Serum free T4 (fT4) and T3 (fT3) levels
are slightly altered but are usually of no clinical significance. Levels of free T
3 and T4 do however decrease slightly in the second and
third trimesters of pregnancy and the normal ranges are reduced.24
Free T3 and T4 are the physiologically important hormones and are
the main determinants of whether a patient is euthyroid.
Serum concentrations of TSH are decreased slightly in the
first trimester in response to the thyrotropic effects of increased levels of human chorionic gonadotropin. Levels of TSH increase
again at the end of the first trimester, and the upper limit in
pregnancy is raised to 5.5 μmol/l compared with the level of 4.0 μmol/l in the non-pregnant state (Table 2).
Pregnancy is associated with a relative iodine deficiency. The
causes for this are active transport of iodine from the mother to the foeto-placental unit and increased iodine excretion in the
urine. The World Health Organisation recommends an increase
in iodine intake in pregnancy from 100 to 150–200 mg/day.
24 If
iodine intake is maintained in pregnancy, the size of the thyroid gland remains unchanged and therefore the presence of goiter
should always be investigated. The thyroid gland is 25% larger in
patients who are iodine deficient.
Adrenal gland
Three types of steroids are produced by the adrenal glands: mineralocorticoids, glucocorticoids and sex steroids. The RAA system is stimulated due to reductions in vascular resistance and
blood pressure, causing a three-fold increase in aldosterone levels
in the first trimester and a 10-fold increase in the third trimester.
25,26
Levels of angiotensin II are increased two- to four-fold and renin activity is increased three to four times that of non-pregnant values.
During pregnancy there is also an increase in serum levels
of deoxycorticosterone, corticosteroid-binding globulin (CBG), adrenocorticotropic hormone (ACTH), cortisol and free cortisol.
These changes cause a state of physiological hypercortisolism and
may be clinically manifested by the striae, facial plethora, rising blood pressure or impaired glucose tolerance.
27 Total cortisol levels
increase at the end of the first trimester and are three times higher than non-pregnant values at the end of pregnancy. Hypercortisolism
in late pregnancy is also the result of the production of corticotropin-
releasing hormone by the placenta – one of the triggers for the onset of labour. Diurnal variations in ACTH and cortisol levels are maintained. The hypothalamic–pituitary axis response to exogenous
glucocorticoids is blunted during pregnancy.
table 2. r eference ranges for thyroid function in pregnancy37
Thyroid functionNon-
pregnant1st
trimester2nd
trimester3rd
trimester
fT4 (pmol/l) 9–26 10–16 9–15.5 8–14.5
fT3 (pmol/l) 2.6–5.7 3–7 3–5.5 2.5–5.5
TSH (mU/l) 0.3–4.2 0–5.5 0.5–3.5 0.5–4Lung
volume
(ml)Inspiratory
reserve
volume
Functional
residual
capacityTidal
volume
Respiratory
rate
Fig. 1. Physiological changes in respiratory function in pregnancy.

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 27 , No 2, March/April 2016
AFRICA 93
Pituitary gland
The pituitary gland enlarges in pregnancy and this is mainly due
to proliferation of prolactin-producing cells in the anterior lobe. Serum prolactin levels increase in the first trimester and are 10
times higher at term. The increase in prolactin is most likely due
to increasing serum oestradiol concentrations during pregnancy. Levels of follicle-stimulating hormone (FSH) and luteinising hormone (LH) are undetectable during pregnancy due to the
negative feedback from elevated levels of oestrogen, progesterone
and inhibin.
28 Pituitary growth hormone production is decreased
but serum growth hormone levels are increased due to growth hormone production from the placenta.
The posterior pituitary produces oxytocin and arginine
vasopressin (A VP). Oxytocin levels increase in pregnancy and peak at term. Levels of antidiuretic hormone (ADH) remain unchanged but the decrease in sodium concentration in
pregnancy causes a decrease in osmolality. There is therefore a
resetting of osmoreceptors for ADH release and thirst.
29
Glucose metabolism
Pregnancy is a diabetogenic state and the adaptations in glucose metabolism allow shunting of glucose to the foetus to promote development, while maintaining adequate maternal nutrition.
30
Insulin-secreting pancreatic beta-cells undergo hyperplasia, resulting in increased insulin secretion and increased insulin sensitivity in
early pregnancy, followed by progressive insulin resistance.
31
Maternal insulin resistance begins in the second trimester
and peaks in the third trimester. This is the result of increasing
secretion of diabetogenic hormones such as human placental
lactogen, growth hormone, progesterone, cortisol and prolactin.
These hormones cause a decrease in insulin sensitivity in the peripheral tissues such as adipocytes and skeletal muscle by interfering with insulin receptor signalling.
32 The effect of
the placental hormones on insulin sensitivity is made evident postpartum when there is a sudden decrease in insulin resistance.
33
Insulin levels are increased in both the fasting and postprandial
states in pregnancy. Fasting glucose levels are however decreased
due to:
• increased storage of tissue glycogen
• increased peripheral glucose use
• decrease in glucose production by the liver
• uptake of glucose by the foetus.34
Insulin resistance and relative hypoglycaemia results in lipolysis,
allowing the pregnant mother to preferentially use fat for fuel, preserving the available glucose and amino acids for the foetus and minimising protein catabolism. The placenta allows transfer of
glucose, amino acids and ketones to the foetus but is impermeable
to large lipids. If a woman’s endocrine pancreatic function is impaired, and she is unable to overcome the insulin resistance associated with pregnancy then gestational diabetes develops.
lipid metabolism
There is an increase in total serum cholesterol and triglyceride levels in pregnancy. The increase in triglyceride levels is mainly as a result of increased synthesis by the liver and decreased lipoprotein
lipase activity, resulting in decreased catabolism of adipose tissue.
Low-density lipoprotein (LDL) cholesterol levels also increase and reach 50% at term. High-density lipoprotein levels increase in the first half of pregnancy and fall in the third trimester but concentrations are 15% higher than non-pregnant levels.
Changes in lipid metabolism accommodate the needs of the
developing foetus. Increased triglyceride levels provide for the mother’s energy needs while glucose is spared for the foetus.
The increase in LDL cholesterol is important for placental
steroidogenesis.
protein metabolism
Pregnant women require an increased intake of protein during pregnancy. Amino acids are actively transported across the placenta to fulfill the needs of the developing foetus. During
pregnancy, protein catabolism is decreased as fat stores are used
to provide for energy metabolism.
Calcium metabolism
The average foetus requires about 30 g of calcium to maintain its physiological processes. Most of this calcium is transferred to the foetus during the third trimester and is derived from increased dietary absorption by the mother.
35 There is a decrease in total
serum calcium concentration during pregnancy. This is mainly due to a decrease in serum albumin levels due to haemodilution,
resulting in a decrease in the albumin-bound fraction of calcium.
However the physiologically important fraction, serum ionised calcium, remains unchanged.
36 Therefore maternal serum levels
of calcium are maintained during pregnancy and foetal needs are met by increased intestinal absorption, which doubles from 12
weeks’ gestation. However the peak demand for calcium is only
in the third trimester. This early increase in calcium absorption may allow the maternal skeleton to store calcium in advance.
17
Serum levels of 25-hydroxyvitamin D increase and this is
metabolised further into 1.25-dihydroxyvitamin D. The increase
in 1.25-dihydroxyvitamin D is directly responsible for the
increase in intestinal calcium absorption.36
Increased calcium absorption is associated with an increase in
calcium excretion in the urine and these changes begin from 12 weeks. During periods of fasting, urinary calcium values are low
or normal, confirming that hypercalciuria is the consequence of
increased absorption.
35 Pregnancy is therefore a risk factor for
kidney stones.
Skeletal and bone density changes
There is controversy regarding the effect of pregnancy on maternal bone loss. Although pregnancy and lactation are associated with reversible bone loss, studies do not support an association between
parity and osteoporosis in later life.
25 Bone turnover is low in the
first trimester and increases in the third trimester when foetal
calcium needs are increased. The source of the calcium in the third
trimester is previously stored skeletal calcium.36
A study of bone biopsies in pregnancy has shown a change
in the micro-architectural pattern of bone in pregnancy but not
overall bone mass.36 The changes reflect the need for the maternal
skeleton to be resistant to bending forces and biochemical stresses needed to carry the growing foetus.
Other musculoskeletal changes seen in pregnancy include:
• exaggerated lordosis of the lower back, forward flexion of the neck and downward movement of the shoulders

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 27 , No 2, March/April 2016
94
AFRICA
• joint laxity in the anterior and longitudinal ligaments of the
lumbar spine
• widening and increased mobility of the sacroiliac joints and
pubic symphysis.
References
1. Locktich G. Clinical biochemistry of pregnancy. Crit Rev Clin Lab Sci
1997; 34: 6.
2. Rodger M, Sheppard D, Gandara E, Tinmouth A. Haematological
problems in obstetrics. Best Prac Res Clin Obstet Gynaecol 2015; 29(5): 671–684.
3. Ramsay M. Normal hematological changes during pregnancy and the puerperium. In Pavord S, Hunt B (ed). The Obstetric Hematology
Manual. Cambridge: Cambridge University Press, 2010: 3–12.
4. Wilson M, Morganti AA, Zervoudakis I, Letcher RL, Romney BM, Von Oeyon P, et al. Blood pressure, the renin-aldosterone system and sex steroids throughout normal pregnancy. Am J Med 1980; 68(1): 97–104.
5. Davison JM. Renal haemodynamics and volume homeostasis in preg-nancy. Scand J Clin Lab Invest Suppl 1984; 169: 15–27.
6. Tkachenko O, Shchekochikhin D, Schrier RW . Hormones and hemody-namics in pregnancy. Int J Endocrinol Metab 2014; 12(2): e14098.
7. Conrad KP . Emerging role of relaxin in the maternal adaptations to
normal pregnancy: implications for preeclampsia. Semin Nephrol 2011;
31(1): 15–32.
8. Gant NF, Worley RJ, Everett RB, MacDonald PC. Control of vascu-
lar responsiveness during human pregnancy. Kidney Int 1980; 18(2):
253–258.
9. Irani RA, Xia Y . Renin angiotensin signaling in normal pregnancy and preeclampsia. Semin Nephrol 2011; 31(1): 47–58.
10. Conrad KP, Davison JM. The renal circulation in normal pregnancy
and preeclampsia: is there a place for relaxin? Am J Physiol Renal
Physiol 2014; 306(10): F1121–1135.
11. Cheung KL, Lafayette RA. Renal physiology of pregnancy. Adv Chronic
Kidney Dis 2013; 20(3): 209–214.
12. Rasmussen PE, Nielsen FR. Hydronephrosis during pregnancy: a literature survey. Eur J Obstet Gynecol Reprod Biol 1988; 27(3): 249–259.
13. Lumbers ER, Pringle KG. Roles of the circulating renin-angiotensin-
aldosterone system in human pregnancy. Am J Physiol Regul Integr
Comp Physiol 2014; 306(2): R91–101.
14. Krop M, Danser AH. Circulating versus tissue renin-angiotensin
system: on the origin of (pro)renin. Curr Hypertens Rep 2008; 10(2):
112–118.
15. Gonzalez-Campoy JM, Romero JC, Knox FG. Escape from the sodium-
retaining effects of mineralocorticoids: role of ANF and intrarenal
hormone systems. Kidney Int 1989; 35(3): 767–777.
16. Davison JM, Gilmore EA, Durr J, Robertson GL, Lindheimer MD. Altered osmotic thresholds for vasopressin secretion and thirst in human pregnancy. Am J Physiol 1984; 246(1 Pt 2): F105–109.
17. Davison JM, Sheills EA, Barron WM, Robinson AG, Lindheimer MD. Changes in the metabolic clearance of vasopressin and in plasma vasopressinase throughout human pregnancy. J Clin Invest 1989; 83(4):
1313–1318.18. Castro LC, Hobel CJ, Gornbein J. Plasma levels of atrial natriuretic
peptide in normal and hypertensive pregnancies: a meta-analysis. Am J Obstet Gynecol 1994; 171(6): 1642–1651.
19. American College of Obstatrics and Gynecology (ACOG) Practice Bulletin. Nausea and vomiting of pregnancy. Obstet Gynecol 2004; 103(4): 803–814.
20. Verberg MF, Gillot DJ, Al-Fardan N, Grudzinskas JG. Hyperemesis gravidarum, a literature review. Hum Reprod Update 2005; 11(5): 527–539.
21. Clark SM, Costantine MM, Hankins GF . Review of NVP and HG and early pharmacotherapeutic intervention. Obstet Gynecol Int 2012; 2012: 252676.
22. Niebyl JR, Goodwin JM. Overview of nausea and vomiting of preg-nancy with an emphasis on vitamins and ginger. Am J Obstet Gynecol
2002; 186(5 Suppl Understanding): S253–255.
23. Koch KL. Gastrointestinal factors in nausea and vomiting of pregnan-cy. Am J Obstet Gynecol 2002; 186(5 Suppl Understanding): S198–203.
24. Glinoer D. The regulation of thyroid function in pregnancy: pathways
of endocrine adaptation from physiology to pathology. Endocr Rev
1997; 18: 404.
25. Dorr HG, Heller A, Versmold HT, et al. Longitudinal study of proges-
tins, mineralocorticoids and glucocorticoids throughout human preg-nancy. J Clin Endocrinol Metabol 1989; 68: 863.
26. Elsheikh A, Creatsas G, Mastorakos G, et al. The renin-aldosterone system during normal and hypertensive pregnancy. Arch Gynecol Obstet
2001; 264: 182.
27. Gordon MC. Maternal Physiology in Obstetrics: Normal and Problem
pregnancies. 6th edn. Philadelphia: Saunders, Elsevier, 2012.
28. Prager D, Braunstein G. Pituitary disorders during pregnancy.
Endocrinol Metab Clin North Am 1995; 24: 1.
29. Linheimer MD, Barron WM, Davison JM. Osmotic and volume control
of vasopressin release in pregnancy. Am J Kidney Dis 1991; 17: 105.
30. Angueira AR, Ludvik AE, Reddy TE, Wicksteed B, et al. New insights into gestational glucose metabolism: lessons learned from 21
st century
approaches. Diabetes 2015; 64: 327–334.
31. Butte NF . Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus. Am J Clin Nutr 2000; 71:
125S.
32. Newbern D, Freemark M. Placental hormones and the control of mater –
nal metabolism and fetal growth. Curr Opin Endocrinol Diabetes Obes
2011; 18: 409–416.
33. Mazaki-Tovi S, Kanety H, Pariente C, et al. Insulin sensitivity in late
gestational and early postpartum period: the role of circulating maternal adipokines. Gynecol Endocrinol 2011; 27: 725–731.
34. Brizzi P, Tonolo G, Esposito F, et al. Lipoprotein metabolism during normal pregnancy. Am J Obstet Gynecol 1999; 181: 430.
35. Kovacs CS. Calcium metabolism during pregnancy and lactation. NCBI Bookshelf. http://www.ncbi.nlm.nih.gov/books/NBK279173/.
36. Woodrow JP, Sharpe CJ, Fudge NJ, Hoff AO, Gagel RF, Kovacs CS.
Calcitonin plays a critical role in regulating skeletal mineral metabolism
during lactation. Endocrinology 2006; 147: 4010–4021.
37. Nelson-Piercy C. Handbook of Obstetric Medicine. 5th edn. London:
CRC Press, 2015.